Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rejection; Transplant, Liver”

83 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 83 results

Not applicableEnrolling By InvitationNCT06061341
What this trial is testing

TruGraf Liver Gene Expression Serial Test

Who this might be right for
Autoimmune Liver DiseaseAutoimmune HepatitisPrimary Sclerosing Cholangitis+1 more
Washington University School of Medicine 20
Not applicableUnknownNCT03603548
What this trial is testing

Comparison of Safety and Efficacy of Two Variants of Prolonged - Released Tacrolimus (Advagraf vs. Envarsus ) in Patients After Liver Transplantation : Single Center Randomised Control Trial

Who this might be right for
Liver Transplant RejectionImmunosuppression
Medical University of Warsaw 200
Not applicableStudy completedNCT01764581
What this trial is testing

Randomized Controlled Trial of ImmuKnow in Liver Transplantation

Who this might be right for
Liver Disease
University of Bologna 206
Not applicableUnknownNCT03815864
What this trial is testing

Antibodies and Liver Retransplantation

Who this might be right for
Liver Transplant FailureAntibody-mediated Rejection
London Health Sciences Centre 200
Not applicableUnknownNCT05335551
What this trial is testing

TRU-IMMUNO: Optimizing Liver Immunosuppression

Who this might be right for
Liver Transplant Rejection
Transplant Genomics, Inc. 130
Not applicableLooking for participantsNCT01757730
What this trial is testing

Magnetic Resonance Elastography as a Method to Estimate Stiffness of Soft Tissues

Who this might be right for
Heart FailureLiver FibrosisCardiac Transplant Rejection+1 more
Arunark Kolipaka 1,000
Not applicableLooking for participantsNCT04838171
What this trial is testing

Prospective Study of White Blood Cells

Who this might be right for
Autoimmune DiseasesInflammationRejection; Transplant, Liver
Quell Therapeutics Limited 10
Not applicableUnknownNCT03882164
What this trial is testing

Blood-Bile Ratio Tacrolimus After Liver Transplantation

Who this might be right for
Liver Transplant; ComplicationsImmunosuppressionTransplant Failure+1 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 55
Not applicableStudy completedNCT00096733
What this trial is testing

Adult-to-Adult Living Donor Liver Transplantation Study

Who this might be right for
CirrhosisHepatitis CHepatocellular Carcinoma
Arbor Research Collaborative for Health 2,470
Testing effectiveness (Phase 2)Study completedNCT01745731
What this trial is testing

Cell Infusion Intraportal Autologous Bone Marrow Mononuclear as Enhancer of Liver Regeneration

Who this might be right for
Liver Transplant Rejection
Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud 13
Testing effectiveness (Phase 2)Study completedNCT04488094
What this trial is testing

Diagnostic Validity of [18F]FSPG PET for the Assessment of Acute Rejection After Heart or Liver Transplantation

Who this might be right for
Graft RejectionHeart TransplantationLiver Transplantation
Asan Medical Center 7
Large-scale testing (Phase 3)Study completedNCT02040584
What this trial is testing

A Multicentre, Randomised, Open-label, Controlled, 12-month Follow-up Study to Assess Impact on Renal Function of an Immunosuppression Regimen Based on Tacrolimus Minimisation in Association With Everolimus in de Novo Liver Transplant Recipients.

Who this might be right for
Liver Transplant
Novartis Pharmaceuticals 217
Testing effectiveness (Phase 2)Looking for participantsNCT07053488
What this trial is testing

CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection

Who this might be right for
Liver DiseasesLiver CancerLiver Cirrhosis+4 more
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC 90
Post-approval studies (Phase 4)Study completedNCT00206076
What this trial is testing

Mycophenolate Mofetil Immunosuppression Without/With Reduced Dose Calcineurin Inhibitor Long After Liver Transplantation

Who this might be right for
Liver Disease
Albert Einstein Healthcare Network 19
Not applicableStudy completedNCT02223468
What this trial is testing

Human Microbiota and Liver Transplant

Who this might be right for
Intestinal MicrobiotaComplication of Transplanted LiverAcute Rejection of Liver Transplant+1 more
Hospital Vall d'Hebron 40
Not applicableUnknownNCT05411926
What this trial is testing

Effect of PD-1 /PD-L1 Inhibitor Therapy Before Liver Transplantation on Acute Rejection After Liver Transplantation in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaAcute Rejection
Beijing Tsinghua Chang Gung Hospital 30
Not applicableStudy completedNCT01678937
What this trial is testing

Immune Tolerance and Alloreactivity in Liver Transplant Recipients on Different Monotherapy Immunosuppressive Agents

Who this might be right for
Liver Transplant RejectionImmunosuppression
Northwestern University 31
Testing effectiveness (Phase 2)Study completedNCT03304626
What this trial is testing

Budesonide for Liver Transplant Immune Suppression

Who this might be right for
Acute Cellular Graft RejectionNew Onset Diabetes After Transplant
University of Cincinnati 40
Testing effectiveness (Phase 2)Looking for participantsNCT06254248
What this trial is testing

Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Liver TransplantHepatocellular Carcinoma RecurrentSystemic Treatment
Assistance Publique - Hôpitaux de Paris 50
Testing effectiveness (Phase 2)Ended earlyNCT03781414
What this trial is testing

Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Liver Transplant Recipients With Additional 12-month Follow-up and Long-term Extension

Who this might be right for
Liver Transplant Rejection
Novartis Pharmaceuticals 129
Load More Results